Navigation Links
NeurogesX to Present at UBS 2007 Global Life Sciences Conference
Date:9/19/2007

SAN CARLOS, Calif., Sept. 19 /PRNewswire-FirstCall/ -- NeurogesX, Inc. (Nasdaq: NGSX), a biopharmaceutical company focused on developing novel pain management therapies, announced today that it is scheduled to present at the 2007 UBS Global Life Sciences Conference on Tuesday, September 25, 2007. Anthony DiTonno, President and Chief Executive Officer, and Jeffery Tobias, Chief Medical Officer, will be presenting.

Date: Tuesday, September 25, 2007

Time: 9:00 a.m. EDT

Place: Grand Hyatt Hotel, New York, NY

An audio Web cast of the Company's presentation will be available by going to the investor relations section of NeurogesX's Web site at http://www.neurogesx.com. A replay of the presentation will be available for 30 days.

About NeurogesX, Inc.

NeurogesX (Nasdaq: NGSX) is a biopharmaceutical company focused on developing novel pain management therapies. Its initial focus is on chronic peripheral neuropathic pain, including postherpetic neuralgia (PHN), painful HIV-distal sensory polyneuropathy (HIV-DSP) and painful diabetic neuropathy. NeurogesX' late stage product portfolio is led by its product candidate NGX-4010, a topical patch designed to manage pain associated with peripheral neuropathic pain conditions, that the company believes offers significant advantages over other pain therapies. Three Phase 3 clinical trials with NGX-4010 have been completed and have met their primary endp
'/>"/>

SOURCE NeurogesX
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Amplification of genome-representative DNA from limited sources with GenomePlex WGA technology for use in genetic alterations studies
2. Wisconsin firms to present at Cleantech venture capital event
3. New Sonic Foundry search engine finds words, phrases in video presentations
4. Lone Wisconsin firm to present at InvestMidwest
5. Sonic Foundry creates search engine for 7,000 expert video presentations
6. InvestMidWest calls for business presentations
7. Wicab to present BrainPort at Boston conference
8. Three more Wisconsin firms to present at venture forum
9. Six Wisconsin firms to present at BIO Mid-America VentureForum
10. New Health and Human Services representative for Midwest
11. Top 20 big pharmas represent majority of world pharma market
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/10/2014)... (PRWEB) July 10, 2014 OMICS Group’s ... techniques during 18-20 August, 2014 at Double Tree by ... the recent developments in Analytical & Bioanalytical research methods ... , Speaking on this occasion, Dr. Srinubabu Gedela, MD ... Acta conference is a remarkable one in bringing a ...
(Date:7/10/2014)... Calabasas, CA (PRWEB) July 10, 2014 ... academic institutions and professional associations, addressed the challenges of ... & Medical Device Industries” through strategic sourcing. Describing the ... ) with the Supply Chain Management Institute ( SCMI) ... the event on June 24 at the Kroc Institute ...
(Date:7/10/2014)... 10, 2014 On July 9 ... , presented Russia,s first national ... The Company is developing a unique project called ... develops a number of innovative drugs based on monoclonal ... ceremony took place at the International Exhibition "Innoprom 2014" ...
(Date:7/10/2014)... 10, 2014 /PRNewswire-iReach/ -- Tute Genomics, the ... announced an agreement with Lineagen, Inc., to ... NextStep Dx PLUS.  Lineagen, focused on ... disorders, currently offers FirstStep Dx PLUS, ... used by healthcare providers as a first-line ...
Breaking Biology Technology:A Critical Review of Analytical Techniques for Improved Living Standards 2A Critical Review of Analytical Techniques for Improved Living Standards 3A Critical Review of Analytical Techniques for Improved Living Standards 4Biotech & Biopharm Supply Chain Management Executives Launch BSMA in San Diego 2Biotech & Biopharm Supply Chain Management Executives Launch BSMA in San Diego 3Biotech & Biopharm Supply Chain Management Executives Launch BSMA in San Diego 4Dmitry Medvedev Presented BIOCAD the First National "Industry" Award 2Tute Genomics Platform Selected to Provide Clinical Interpretation for Lineagen's NextStepDx PLUS Next-Generation Sequencing-Based Diagnostic Test 2Tute Genomics Platform Selected to Provide Clinical Interpretation for Lineagen's NextStepDx PLUS Next-Generation Sequencing-Based Diagnostic Test 3Tute Genomics Platform Selected to Provide Clinical Interpretation for Lineagen's NextStepDx PLUS Next-Generation Sequencing-Based Diagnostic Test 4
... in Physics from the Public University of Navarre and ... studied the behaviour and properties of nanometric-scale semiconductor crystals. ... Dr Echeverra to study the behaviour of semiconductor crystals ... hundred nanometres (a nanometre is a millionth part of ...
... Corporation (Nasdaq: SIAL ) will be presenting at ... 21st at 12:30 PM ET in New York, NY. Interested ... available at http://investor.sigmaaldrich.com/ .  Users can click the "Webcast" ... Sigma-Aldrich: Sigma-Aldrich is a leading Life Science and ...
... Sept. 15 iPierian, Inc., the leading biopharmaceutical company ... discovery, today announced that FierceBiotech has named iPierian  as ... of the most promising biotech companies in the industry. ... its annual list, which is based on a variety ...
Cached Biology Technology:Ph.D. study of behavior of semiconductor crystals of size less than 100 nanometers 2FierceBiotech Names iPierian as One of the 'Fierce 15' Biotech Companies of 2010 2
(Date:7/11/2014)... animals often develop relationships with other group members to ... wild chacma baboons the strategy for grooming activities shows ... just published in the scientific journal Biology Letters ... baboons is not practiced without ulterior motives. To be ... the individual, while grooming another individual can provide access ...
(Date:7/11/2014)... of kidney injury related to the use of hydroxyethyl ... HES molecules, according to a report in Anesthesia ... Research Society (IARS). , The "total mass of HES ... human renal proximal tubule cells (PTCs), concludes the laboratory ... Hospital Wrzburg, Austria. Other factorssuch as differences in ...
(Date:7/11/2014)... that cannabinoid receptor type 1 can inhibit ... and reduce neurotransmitter release. However, some scholars ... increase extracellular Ca2+ influx and increase neurotransmitter ... Tongji Hospital Affiliated to Tongji Medical College, ... used whole cell voltage-clamp and calcium imaging ...
Breaking Biology News(10 mins):Baboons groom early in the day to get benefits later 2In lab studies, hydroxyethyl starch has direct harmful effects on kidney cells 2
... decade and a half of near stagnation, four new drugs ... of a terminal disease, a leading Colorado prostate cancer expert ... and innovative methods of action. One is a bone protective ... and the final one is the first drug tested for ...
... can tell cells to act cancerous, surviving, growing and ... cells with cancerous characteristics to stop growing or to ... does both sometimes promoting tumors and sometimes suppressing ... recently published in the journal Oncogene details ...
... have demonstrated a new and more effective method for ... a research advancement that could have major implications for ... death in the Western world. The treatment method ... Baker could allow doctors to bypass surgery and instead ...
Cached Biology News:4 new drugs will change prostate cancer care 2Study details on-off switch that promotes or suppresses breast cancer 2New ability to regrow blood vessels holds promise for treatment of heart disease 2New ability to regrow blood vessels holds promise for treatment of heart disease 3
Chicken anti-EEA1...
Request Info...
IHC Detection Kit (Broad Spectrum AEC)....
... Cell Dissociation Buffers are membrane-filtered isotonic ... chelating agents and cell-conditioning agents in ... salt solution or Ca2+- and ... of mammalian cells from support substrates ...
Biology Products: